Unilens Vision (fka UVIC)

[Greenaccountingbean]

Thanks
Glad I held to see this bought out at a decent price

[Renee]

UVIC: cash merger of Unilens Vision, Inc. (UVIC) where shareholders will receive $12.75 per share.

FINRA deleted symbol:

http://otce.finra.org/DLDeletions

[10 bagger]

UVIC..

No updates to report since last post....

[btmfdr]

hi 10 Bagger, great to see Unilens getting some attention on these boards!

[10 bagger]

07/29/2011 3.06 3.06 3.06 3.06 1,900
07/28/2011 3.05 - - 3.05 0
07/27/2011 3.05 - - 3.05 0
07/26/2011 3.05 3.05 3.05 3.05 2,000
07/25/2011 3.05 - - 3.05 0
07/22/2011 3.05 - - 3.05 0
07/21/2011 3.05 3.05 3.05 3.05 500
07/20/2011 3.00 3.00 3.00 3.00 2,300
07/19/2011 3.50 - - 3.50 0
07/18/2011 3.50 - - 3.50 0
07/15/2011 3.50 - - 3.50 0
07/14/2011 3.00 3.50 2.70 3.50 550
07/13/2011 2.90 - - 2.90 0
07/12/2011 2.98 2.98 2.90 2.90 5,000
07/11/2011 3.50 - - 3.50 0
07/08/2011 3.50 - - 3.50 0
07/07/2011 3.50 - - 3.50 0
07/06/2011 3.50 3.50 3.50 3.50 936
07/05/2011 4.16 4.16 4.16 4.16 300
07/01/2011 2.95 - - 2.95 0
06/30/2011 3.05 3.05 2.63 2.95 6,100
06/29/2011 3.50 3.50 3.05 3.05 1,200
06/28/2011 3.65 - - 3.65 0
06/27/2011 3.65 3.65 3.65 3.65 600
06/24/2011 3.25 - - 3.25 0
06/23/2011 3.25 - - 3.25 0
06/22/2011 3.25 - - 3.25 0
06/21/2011 3.25 - - 3.25 0
06/20/2011 3.25 3.25 3.25 3.25 400
06/17/2011 3.25 3.25 3.25 3.25 1,000
06/16/2011 3.69 - - 3.69 0
06/15/2011 3.69 - - 3.69 0
06/14/2011 3.69 - - 3.69 0
06/13/2011 3.69 - - 3.69 0
06/10/2011 3.69 - - 3.69 0
06/09/2011 3.70 3.70 3.69 3.69 3,089
06/08/2011 3.10 3.10 3.10 3.10 1,000
06/07/2011 3.24 3.25 3.20 3.20 6,500
06/06/2011 2.66 3.01 2.66 3.00 11,500
06/03/2011 3.00 3.00 3.00 3.00 10,125
06/02/2011 3.50 - - 3.50 0
06/01/2011 3.07 3.50 3.07 3.50 5,350
05/31/2011 3.50 3.60 3.50 3.60 4,150
05/27/2011 3.50 3.50 3.50 3.50 857
05/26/2011 3.50 - - 3.50 0
05/25/2011 2.56 3.50 2.56 3.50 1,779
05/24/2011 3.50 - - 3.50 0
05/23/2011 3.50 3.55 3.50 3.50 10,700
05/20/2011 3.50 3.50 3.35 3.50 10,800
05/19/2011 3.25 3.35 3.25 3.35 1,700
05/18/2011 3.25 3.25 3.25 3.25 5,300
05/17/2011 3.77 3.77 2.56 3.50 4,550
05/16/2011 3.85 3.98 3.77 3.85 4,600
05/13/2011 3.80 3.80 3.80 3.80 2,700
05/12/2011 4.00 4.00 3.80 3.80 5,546
05/11/2011 4.05 - - 4.05 0
05/10/2011 4.10 4.10 4.10 4.05 500
05/09/2011 4.10 4.10 4.10 4.10 10,200
05/06/2011 4.10 - - 4.10 0
05/05/2011 4.10 4.10 4.10 4.10 1,000
05/04/2011 4.10 - - 4.10 0
05/03/2011 4.10 4.10 4.10 4.10 3,300
05/02/2011 4.10 4.10 4.10 4.10 1,000
04/29/2011 4.25 - - 4.25 0
04/28/2011 4.25 4.25 4.25 4.25 4,193
04/27/2011 4.20 - - 4.20 0
04/26/2011 4.20 4.20 4.20 4.20 950
04/25/2011 4.25 4.25 4.25 4.25 11,800
04/21/2011 4.40 - - 4.40 0
04/20/2011 4.10 4.40 4.10 4.40 2,700
04/19/2011 4.22 4.22 4.22 4.22 925
04/18/2011 4.25 - - 4.25 0
04/15/2011 4.25 4.25 4.25 4.25 4,600
04/14/2011 4.25 - - 4.25 0
04/13/2011 4.25 - - 4.25 0
04/12/2011 4.25 4.25 4.25 4.25 1,200
04/11/2011 4.25 4.25 4.25 4.25 2,500
04/08/2011 4.15 4.20 4.15 4.20 1,922
04/07/2011 4.10 4.10 4.08 4.08 1,400
04/06/2011 3.13 4.25 3.13 4.22 10,370
04/05/2011 4.10 4.20 4.10 4.20 5,195
04/04/2011 4.38 4.38 4.00 4.10 41,034
04/01/2011 4.60 - - 4.60 0
03/31/2011 4.60 - - 4.60 0
03/30/2011 4.60 4.60 4.60 4.60 100
03/29/2011 4.45 4.79 4.45 4.60 7,334
03/28/2011 4.65 4.65 4.65 4.65 3,700
03/25/2011 4.40 4.40 4.40 4.40 500
03/24/2011 4.50 4.79 4.50 4.79 1,140
03/23/2011 4.65 4.66 4.65 4.66 1,800
03/22/2011 4.79 4.79 4.79 4.79 212
03/21/2011 4.70 4.70 4.70 4.70 200
03/18/2011 4.89 4.89 4.80 4.80 2,358
03/17/2011 4.60 - - 4.60 0
03/16/2011 4.60 4.60 4.60 4.60 900
03/15/2011 4.40 4.60 4.40 4.55 10,500
03/14/2011 4.65 - - 4.65 0
03/11/2011 4.65 4.85 4.65 4.65 9,600
03/10/2011 4.91 - - 4.91 0
03/09/2011 4.90 4.91 4.90 4.91 1,265
03/08/2011 4.43 4.43 4.43 4.43 315
03/07/2011 4.65 4.76 4.65 4.65 3,888
03/04/2011 4.65 - - 4.65 0
03/03/2011 4.41 4.65 4.41 4.65 562
03/02/2011 4.75 4.75 4.65 4.65 1,800
03/01/2011 4.60 - - 4.60 0
02/28/2011 4.60 4.60 4.60 4.60 347
02/25/2011 4.50 4.50 4.50 4.50 335
02/24/2011 4.60 - - 4.60 0
02/23/2011 4.60 4.60 4.60 4.60 2,935
02/22/2011 4.50 - - 4.50 0
02/18/2011 4.50 - - 4.50 0
02/17/2011 4.50 4.50 4.50 4.50 1,100
02/16/2011 4.50 4.60 4.45 4.60 2,400
02/15/2011 4.34 4.50 4.34 4.50 800
02/14/2011 4.69 4.69 4.55 4.55 2,200
02/11/2011 4.73 4.73 4.70 4.70 3,400
02/10/2011 4.71 4.71 4.71 4.71 500
02/09/2011 4.16 4.73 4.16 4.72 2,486
02/08/2011 4.50 4.60 4.30 4.50 26,700
02/07/2011 4.336 - - 4.336 0
02/04/2011 4.89 4.89 4.336 4.336 700
02/03/2011 4.40 - - 4.40 0
02/02/2011 4.40 4.40 4.40 4.40 600
02/01/2011 4.40 4.40 4.40 4.40 1,000
01/31/2011 4.45 - - 4.45 0
01/28/2011 4.45 - - 4.45 0
01/27/2011 4.72 4.72 4.266 4.45 3,520
01/26/2011 4.50 4.74 4.50 4.74 3,600
01/25/2011 4.58 - - 4.58 0
01/24/2011 4.58 4.58 4.58 4.58 1,500
01/21/2011 4.74 4.74 4.74 4.74 400
01/20/2011 4.571 - - 4.571 0
01/19/2011 4.571 - - 4.571 0
01/18/2011 4.587 4.60 4.57 4.571 11,850
01/14/2011 4.41 4.41 4.41 4.41 150
01/13/2011 4.50 - - 4.50 0
01/12/2011 4.50 - - 4.50 0
01/11/2011 4.50 - - 4.50 0
01/10/2011 4.50 4.50 4.50 4.50 500
01/07/2011 4.50 - - 4.50 0
01/06/2011 4.50 - - 4.50 0
01/05/2011 4.37 4.50 4.37 4.50 4,500
01/04/2011 4.36 - - 4.36 0
01/03/2011 4.36 4.36 4.36 4.36 500
12/31/2010 4.40 4.40 4.35 4.35 2,325

[10 bagger]

UVIC.. $3.07 Dividend..

Unilens Vision, Inc. (UVIC) Declares $0.045 Quarterly Dividend; 5.9% Yield


Street Insider - Aug 01 08:34 EDT

Alert hits:all med (/u
Company Symbols: OTC-PINK:UVIC, TorontoVE:UVI


Unilens Vision, Inc. (: UVIC) declared a quarterly dividend of $0.045 per share, or $0.18 annualized.

The dividend will be payable on August 26, 2011, to stockholders of record on August 12, 2011, with an ex-dividend date of August 10, 2011.

The annual yield on the dividend is 5.9 percent.

[10 bagger]

Unilens Vision Reports Higher Third Quarter Sales and Net Income, as Custom Soft Lens Sales Rise 34% in Response to Successful New Product Launches

Marketwire - May 16 08:28 EDT

Alert hits:(/u
Company Symbols: OTC-PINK:UVIC, TorontoVE:UVI, ACORN:A.1203525542, ACORN:A.750141051

Diluted EPS Increase 30% on Fewer Diluted Shares Outstanding

LARGO, FL -- (MARKET WIRE) -- 05/16/11 -- Unilens Vision Inc. (OTCBB: UVIC) (TSX-V: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the third quarter and first nine months of FY2011.

For the three months ended March 31, 2011 (third quarter of FY2011), total revenue including royalty income declined 4.4% to approximately $2.2 million, compared with approximately $2.3 million in the three months ended March 31, 2010. Sales of the Company's specialty contact lenses were relatively unchanged at approximately $1.5 million in the third quarter of each fiscal year. Royalty income decreased 14.0% to approximately $0.6 million in the most recent quarter, compared with approximately $0.7 million in the prior-year quarter. Declines in sales of disposable contact lenses and replacement/other lens categories were more than offset by increased sales of the Company's custom soft lenses during the quarter. The Company believes that the continued impact of a soft U.S. economy upon the specialty contact lens market and a competitor's new disposable multifocal lenses and rebate programs, were primarily responsible for softness in sales and royalty income in the third quarter of FY2011, when compared with the year-earlier period.

Pretax income decreased 1.9% to $442,177 in the third quarter of FY2011, compared with $450,559 in the quarter ended March 31, 2010. The modest decline in pretax income was primarily attributable to lower royalty income and gross profits, largely offset by a 12.9% decrease in selling, general and administrative (SG&A) expenses.

The Company reported net income of $296,792 in the most recent quarter, for an increase of 7.7% when compared with net income of $275,569 in last year's third fiscal quarter. The Company earned $0.13 per diluted share in the third quarter of FY2011, which represented an increase of 30.0% versus earnings of $0.10 per diluted share in the third quarter of FY2010. Diluted per-share earnings were calculated on 2,369,354 common shares in the FY2011 third quarter, versus 2,855,684 diluted shares in the prior-year quarter. The 17% decrease in weighted average diluted shares outstanding resulted from the Company's repurchase of a large block of common stock from its previously largest shareholder on January 20, 2010.

"I am very pleased to report that sales in our custom soft lens category increased approximately 34% in the third fiscal quarter, reflecting our continued success in converting customers from the C-Vue Advanced Toric Multifocal lens free trial program into purchasers of revenue-generating boxes, and initial sales of our recently launched C-VUE Advanced® HydraVUE™ line of completely customizable silicone hydrogel contact lenses for monthly replacement," observed Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "Increased sales of these custom soft lenses more than offset declines in our disposable lens category and sales of replacement and other lenses, thereby allowing us to report a modest total sales increase in the most recent quarter. We believe the decline in royalty income from Bausch & Lomb during the third quarter continued to reflect new competitive product offerings and associated rebate programs in the disposable multifocal lens product category."

"Looking forward, we continue to believe that Unilens can realize significant sales growth by targeting the specialty segment of the contact lens market in order to benefit from demographic trends in America, and by working closely with independent eye care practitioners to develop sales and marketing strategies that can increase patient retention and practice profitability," continued Pecora. "As the 40 and over presbyopic population continues to grow faster than the population as a whole, the demand for custom and other specialty contact lenses should increase at an accelerating pace, as well," concluded Pecora.

For the nine months ended March 31, 2011, total revenue including royalty income decreased 6.1% to approximately $6.5 million, compared with approximately $6.9 million in the first nine months of FY2010. The decrease in revenue was primarily due to a 3.7% decline in sales of the Company's various types of specialty contact lenses and an 11.0% decline in royalty income.

Pretax income decreased 23.2% to $1,456,000 in the nine months ended March 31, 2011, compared with $1,895,360 in the prior-year period. The decrease in pretax income was primarily attributable to lower sales, royalty income and gross profit, along with an increase in interest expense related to the Company's loan with Regions Bank, partly offset by a reduction in SG&A expenses.

The Company reported net income of $978,878 for the first nine months of FY2011, a decrease of 18.1% when compared with net income of $1,194,965 in the corresponding period of the previous fiscal year. The Company earned $0.41 per diluted share in the first nine months of FY2011, which represented an increase of 36.7% when compared with earnings of $0.30 per diluted share in the first nine months of FY2010. Diluted per-share earnings were calculated on 2,369,354 common shares in the nine months ended March 31, 2011, versus 3,998,122 diluted shares in the prior-year period.

The Company recently declared its 19th consecutive quarterly cash dividend, in the amount of $0.045 per share of common stock outstanding. The amount and frequency of future dividends will depend upon earnings, cash flow, and other aspects of the Company's business as determined and declared by the Board of Directors.

About Unilens Vision Inc. - "The Independent Eye Care Professionals' Contact Lens Company"

Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida and its wholly owned subsidiary Unilens Vision Sciences Inc. develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue® brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVIC" and on the Canadian TSX Venture Exchange under the symbol "UVI".

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.


UNILENS VISION INC.
THIRD QUARTER - FISCAL 2011
CONDENSED CONSOLIDATED FINANCIAL INFORMATION


(All figures in U.S. Dollars)
RESULTS OF OPERATIONS


Three Months Three Months Nine Months Nine Months
Ended Ended Ended Ended
March March March March
31, 2011 31, 2010 31, 2011 31, 2010
----------- ----------- ----------- -----------
Revenues:
Sales $ 1,539,555 $ 1,535,454 $ 4,462,223 $ 4,633,666
Royalty income 631,893 734,803 2,007,702 2,253,865
----------- ----------- ----------- -----------
Total revenues 2,171,448 2,270,257 6,469,925 6,887,531
----------- ----------- ----------- -----------
Operating costs and
expenses:
Cost of sales 928,612 912,581 2,704,456 2,717,169
Expenses 720,883 827,865 2,088,758 2,204,063
----------- ----------- ----------- -----------
Total operating costs
and expenses 1,649,495 1,740,446 4,793,214 4,921,232
----------- ----------- ----------- -----------
Income from operations 521,953 529,811 1,676,711 1,966,299
----------- ----------- ----------- -----------
Other non-operating
items:
Other expense (13,734) (16,059) (12,289) (15,236)
Remeasurement loss - (3,398) - (1,575)
Interest expense (66,042) (59,795) (208,422) (54,128)
----------- ----------- ----------- -----------
Total other
non-operating items (79,776) (79,252) (220,711) (70,939)
----------- ----------- ----------- -----------
Income before income
tax expense 442,177 450,559 1,456,000 1,895,360
Income tax expense 145,385 174,990 477,122 700,395
----------- ----------- ----------- -----------
Net income for the
period $ 296,792 $ 275,569 $ 978,878 $ 1,194,965
=========== =========== =========== ===========
Net income per common
share:
Basic $ 0.13 $ 0.10 $ 0.41 $ 0.30
Diluted $ 0.13 $ 0.10 $ 0.41 $ 0.30
Weighted average shares
outstanding 2,369,354 2,855,684 2,369,354 3,998,122
=========== =========== =========== ===========
CASH FLOWS
----------- ----------- ----------- -----------
Provided (used) by:
Operating activities $ 1,095,306 $ 2,122,312
Investing activities (140,757) 477,219
Financing activities (1,552,288) (2,691,349)
----------- ----------- ----------- -----------
(Decrease) increase in
cash $ (597,739) $ (91,818)
=========== =========== =========== ===========
June 30, March 31, March 31,
BALANCE SHEET 2010 2011 2010
----------- ----------- ----------- -----------
Cash and cash
equivalents $ 1,080,540 $ 482,801 $ 1,085,233
Total assets 4,467,338 3,858,454 4,552,449
Current liabilities 2,519,513 1,815,126 2,444,815
Total liabilities 6,819,513 5,884,265 7,044,815
Stockholders' (deficit)
equity $(2,352,175) $(2,025,811) $(2,492,366)
=========== =========== =========== ===========

[10 bagger]

Unilens Vision Inc. Declares Quarterly Cash Dividend of $0.045 Per Share

PR Newswire - May 02 11:28 EDT

Alert hits:(/u
Company Symbols: TorontoVE:UVI, OTC-PINK:UVIC


LARGO, Fla., May 2, 2011 /PRNewswire/ -- The Unilens Vision Inc. (OTCBB: UVIC) (OTCQB: UVIC) (TSX Venture Exchange: UVI) Board of Directors today declared a quarterly cash dividend of $0.045 per common share, payable May 27, 2011 to stockholders of record at the close of business on May 13, 2011.

About Unilens Vision Inc. – "The Eye Care Professionals Specialty Contact Lens Company"

Established in 1989, Unilens Vision Inc., a Delaware corporation, through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, and its wholly owned subsidiary Unilens Vision Sciences Inc. develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on OTC Bulletin Board and OTCQB exchanges under the symbol "UVIC" as well as the Canadian TSX Venture Exchange under the symbol "UVI."

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risk and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

For more information, please contact:


Leonard F. Barker, CFO, Unilens Vision Inc. at [phone] or via email at [e-mail]
or
RJ Falkner & Company, Inc., Investor Relations Counsel at [phone] or via email at [e-mail]

SOURCE Unilens Vision Inc.

[10 bagger]

Unilens Vision Inc. Announces Amendment to Term Loan Facility, Capital Equipment Financing and Reduction in Quarterly Cash Dividend

Marketwire - Apr 04 08:28 EDT

Alert hits:(/u
Company Symbols: TorontoVE:UVI, OTC-PINK:UVIC


LARGO, FL -- (MARKET WIRE) -- 04/04/11 -- Unilens Vision Inc. (OTCBB: UVIC) (OTCQB: UVIC) (TSX-V: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced an amendment to its term loan facility with Regions Bank and a reduction to its quarterly cash dividend.

The amendment to the term loan facility reduces the Company's minimum monthly principal repayment from $100,000 to $54,762, retaining the January 2015 expiration date, at which time a final balloon payment will be due, although additional quarterly principal payments (not to exceed the original amortization in the aggregate) will be payable to the extent the Company generates cash flow in excess of certain specified amounts. In addition, Regions Bank is providing the Company with a new seven-year credit facility of up to $500,000 for capital equipment financing.

In conjunction with the amendment to the term loan facility, the Company's Board of Directors has voted to reduce the quarterly cash dividend payable to common shareholders to $0.045 per share from the previous quarterly cash dividend rate of $0.09 per share.

"We are very pleased to announce the amendment to our term loan facility with Regions Bank and the bank's agreement to extend the Company up to $500,000 in credit for capital equipment financing," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "When combined with the reduction in our quarterly cash dividend, our monthly cash flows from operations will improve significantly, thereby allowing us to expand our manufacturing capabilities and further develop our sales and marketing initiatives in support of the growth that we anticipate from our Custom lens category sales in coming years. As the 40 and over presbyopic population continues to grow faster than the population as a whole, we believe the ability to satisfy the increasing demand for existing and future toric multifocal and multifocal contact lens product offerings will create substantial value for our shareholders. Although we considered it necessary to reduce the cash dividend in order to achieve these strategic objectives, the new quarterly cash dividend rate still provides a healthy annualized yield of 3.9%, based upon the most recent closing stock price of $4.60 per share."

About Unilens Vision Inc. -- "The Eye Care Professionals Specialty Contact Lens Company"

Established in 1989, Unilens Vision Inc., a Delaware corporation, through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, and its wholly owned subsidiary Unilens Vision Sciences Inc. develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on OTC Bulletin Board and OTCQB exchanges under the symbol "UVIC" as well as the Canadian TSX Venture Exchange under the symbol "UVI."

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risk and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

For more information, please contact:

Leonard F. Barker
CFO
Unilens Vision Inc.
[phone]
[e-mail]

or

RJ Falkner & Company, Inc.
Investor Relations Counsel
[phone]
[e-mail]

[10 bagger]

Unilens Vision Reports Second Quarter Operating Results, Including 67% Increase in Diluted EPS ($0.15 vs. $0.09) on Fewer Shares Outstanding

Marketwire - Feb 14 15:17 EDT

Alert hits:(/u
Company Symbols: NASDAQ-OTCBB:UVIC, TorontoVE:UVI

Company's Emphasis Upon Specialty Contact Lenses Anticipates Above-Average Growth of America's Presbyopic Population

LARGO, FL -- (MARKET WIRE) -- 02/14/11 -- Unilens Vision Inc. (OTCBB: UVIC) (TSX-V: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the second quarter and first half of FY2011.

For the three months ended December 31, 2010 (second quarter of FY2011), total revenue including royalty income declined 2.6% to approximately $2.1 million, compared with approximately $2.2 million in the three months ended December 31, 2009. Sales of the Company's specialty contact lenses declined 1.5%, while royalty income decreased 4.8%, when compared with the prior-year quarter. The Company believes that the continued impact of a soft U.S. economy upon the specialty contact lens market and new product offerings by competitors were the primary reasons for lower sales and royalty income in the second quarter of FY2011, when compared with the year-earlier quarter.

Pretax income decreased 20.6% to $519,659 in the second quarter of FY2011, compared with $654,071 in the quarter ended December 31, 2009. The reduction in pretax income was primarily attributable to lower sales and royalty income and an increase in interest expense related to the Company's loan with Regions Bank, which financed the repurchase of 48% of the Company's previously outstanding shares in January 2010; partially offset by lower administrative and sales and marketing ("SG&A") expenses.

The Company reported net income of $350,237 in the most recent quarter, a decrease of 17.7% when compared with net income of $425,308 in last year's second fiscal quarter. The Company earned $0.15 per diluted share in the second quarter of FY2011, which represented an increase of 66.7% versus earnings of $0.09 per diluted share in the second quarter of FY2010. Diluted per-share earnings were calculated on 2,369,354 common shares in the FY2011 second quarter, versus 4,557,852 diluted shares in the prior-year quarter. The 48% decrease in weighted average diluted shares outstanding resulted from the Company's repurchase of 2,188,861 outstanding shares of common stock on January 20, 2010.

"Sales of our custom soft lens category increased significantly in the second quarter as our C-Vue Advanced Toric Multifocal lenses continue to gain traction in the marketplace, almost completely offsetting declines in our disposable lens category," observed Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "The C-Vue Advanced Toric Multifocal was introduced in the first quarter of Fiscal 2010 with a free trial option, and sales have increased as eye care professionals convert trial fits to revenue-generating sales. We expect a similar phenomenon over time with our recently introduced C-Vue Advanced® HydraVUE™ line of silicone hydrogel custom contact lenses for monthly replacement, which are completely customizable and feature a risk-free trial program and exceptional deliverability."

"Although sales and royalties were lower than prior-year levels in the second quarter, we are encouraged that the 1.5% decline in our specialty contact lens sales represented an improvement relative to a 9.2% decrease in the first quarter, while the 4.8% decline in royalty income was much less severe than the 14.0% first quarter decrease. Longer-term, we believe that the specialty segment of the contact lens market will benefit significantly as the presbyopic population continues to grow at a faster rate than America's population as a whole, and we have positioned our Company to benefit from such trends by providing independent practitioners with specialty contact lens options that contribute to patient retention and practice profitability," concluded Pecora.

For the six months ended December 31, 2010, net sales including royalty income decreased 7% to approximately $4.3 million, compared with approximately $4.6 million in the first half of FY2010. The decrease in revenue was primarily due to a 5.7% decline in sales of the Company's various types of specialty contact lenses and a 9.4% decline in royalty income.

Pretax income decreased 29.8% to $1,013,823 in the six months ended December 31, 2010, compared with $1,444,801 in the prior-year period. The decrease in pretax income was primarily attributable to lower sales and royalty income and an increase in interest expense related to the Company's loan with Regions Bank, partly offset by a modest reduction in SG&A expenses.

The Company reported net income of $682,086 for the first half of FY2011, a decrease of 25.8% when compared with net income of $919,396 in the corresponding period of the previous fiscal year. The Company earned $0.29 per diluted share in the first six months of FY2011, which represented an increase of 45.0% when compared with earnings of $0.20 per diluted share in the first six months of FY2010. Diluted per-share earnings were calculated on 2,369,354 common shares in the six months ended December 31, 2010, versus 4,556,969 diluted shares in the prior-year period.

The Company recently declared its 18th consecutive quarterly cash dividend, in the amount of $0.09 per share of common stock outstanding. The amount and frequency of future dividends will depend upon earnings, cash flow, and other aspects of the Company's business as determined and declared by the Board of Directors.

About Unilens Vision Inc. -- "The Independent Eye Care Professionals' Contact Lens Company"

Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida and its wholly owned subsidiary Unilens Vision Sciences Inc. develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue® brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVIC" and on the Canadian TSX Venture Exchange under the symbol "UVI."

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.


UNILENS VISION INC.
SECOND QUARTER -- FISCAL 2011
CONDENSED CONSOLIDATED FINANCIAL INFORMATION

(All figures in U.S. Dollars)

RESULTS OF OPERATIONS
Three Three
Months Months Six Months Six Months
Ended Ended Ended Ended
December December December December
31, 2010 31, 2009 31, 2010 31, 2009
---------- ----------- ----------- ----------
Revenues:
Sales $1,393,094 $ 1,414,539 $ 2,922,668 $3,098,212
Royalty income 715,603 751,386 1,375,809 1,519,062
---------- ----------- ----------- ----------
Total revenues 2,108,697 2,165,925 4,298,477 4,617,274
---------- ----------- ----------- ----------
Operating costs and
expenses:
Cost of sales 877,754 843,217 1,775,844 1,804,588
Expenses 641,056 672,989 1,367,875 1,376,198
---------- ----------- ----------- ----------
Total operating costs
and expenses 1,518,810 1,516,206 3,143,719 3,180,786
---------- ----------- ----------- ----------
Income from operations 589,887 649,719 1,154,758 1,436,488
---------- ----------- ----------- ----------
Other non-operating
items:
Other income 900 355 1,445 823
Remeasurement income - 1,288 - 1,823
Interest (expense)
income (71,128) 2,709 (142,380) 5,667
---------- ----------- ----------- ----------
Total other non-operating
items (70,228) 4,352 (140,935) 8,313
---------- ----------- ----------- ----------
Income before income tax
expense 519,659 654,071 1,013,823 1,444,801
Income tax expense 169,422 228,763 331,737 525,405
---------- ----------- ----------- ----------
Net income for the
period $ 350,237 $ 425,308 $ 682,086 $ 919,396
========== =========== =========== ==========
Net income per common
share:
Basic $ 0.15 $ 0.09 $ 0.29 $ 0.20
Diluted $ 0.15 $ 0.09 $ 0.29 $ 0.20
Weighted average shares
outstanding 2,369,354 4,557,852 2,369,354 4,556,969
========== =========== =========== ==========

CASH FLOWS

Provided (used) by:
Operating activities $ 495,440 $1,411,655
Investing activities (131,084) 239,876
Financing activities (1,026,484) (819,128)
----------- ----------
(Decrease) increase in cash $ (662,128) $ 832,403
=========== ==========

BALANCE SHEET June 30, December December
2010 31, 2010 31, 2009
----------- ----------- ----------
Cash and cash equivalents $ 1,080,540 $ 418,412 $2,262,852
Total assets 4,467,338 4,099,157 5,975,079
Current liabilities 2,519,513 2,378,192 1,181,462
Total liabilities 6,819,513 6,217,768 1,181,462
Stockholders' (deficit)
equity $(2,352,175) $(2,118,611) $4,793,617
=========== =========== ==========


For more information, please contact:

Leonard F. Barker
CFO
Unilens Vision Inc.
[phone]
[e-mail]

or

RJ Falkner & Company, Inc.
Investor Relations Counsel
[phone]
[e-mail]

[10 bagger]

UVIC.. $03.09

Aththe current leveland new products on stream,, UVIC should trade higher in the next year.. While not a barn burner UVIC offers downside protection with it's dividend...

Unilens Vision, Inc. (UVIC) Declares $0.045 Quarterly Dividend; 5.9% Yield

Street Insider - Aug 01 08:34 EDT

Alert hits:all med (/u
Company Symbols: OTC-PINK:UVIC, TorontoVE:UVI


Unilens Vision, Inc. (: UVIC) declared a quarterly dividend of $0.045 per share, or $0.18 annualized.

The dividend will be payable on August 26, 2011, to stockholders of record on August 12, 2011, with an ex-dividend date of August 10, 2011.

The annual yield on the dividend is 5.9 percent.

[btmfdr]

The interest here in the company really dried up quickly. The report wasnt bad, looks to me like they stopped losing sales.

[amatuer33]

The only thing im comfortable doing a DCF calclulation is my hewlett packard calc which is lost but Ill try and explain my reasoning whithout any hard numbers.

If you assume the royalty income continues in its present amount, it's about 2.8 million a year. Ill just say three.

So 3 mil for six years is 18 mil. Or less depending on the rate you use. The market value of the stock with the new share count is around 12.4 mil. And then theres about 4 mil of debt net of cash and recievables, inventory etc.

When the share repurchase was announced, I wondered how bausch and lomb missed that one. The royalty they pay alone would have been able to finance the stock purchase.

I guess what I was thinking was let the cash flows from the royalty finance the buyout and you get 6 million of annual revenues for very very cheap. Seems to me those numbers would jive for a bausch and lomb or a coopervision looking to grow revenues by aquisition.

[ghmm]

OK I keep saying I haven't sat down and done a DCF so here is a link for anyone that is curious and you can plug in your own assumptions.

http://www.lasvegas4us.com/JwwDCF/discounted_cash_flow_calculator.htm

After plugging in a few things one thing I could see is perhaps Baker Street would try to get the company to liquidate its current business and sell the royalty? To me its not worth the risk for the upside at the levels they paid anyway.

[ghmm]

I haven't sat down and done a DCF but I think there would have to be a non-trivial amount of royalty income in 2016 and beyond (when the last adjustment occurs to the royalty) for the present value of the royalty to be worth more then the current share price. Since I sold out my thinking was/is there is very little to nothing coming from the royalty when the patents end. So one is left with the underlying business which from the PR looked negative. I am not sure what Baker Street Capital sees perhaps they have more insight into the royalty or see something I am missing?

[amatuer33]

I sold half my position friday. Had a feeling it was Baker Street Capital that set the price at 4.60 and was buying anything and everything. Its now a twenty percent owner.

I was expecting the royalty income to increase at least. They are not making enough right now to even cover the dividend after paying down the principle on the note.

I wonder if someones intending to sell this comapany out. The present value of the royalty income out six and a half years is worth close to the value of the stock right now I imagine. Went looking for my financial calculator but it has dissappeared.

[ghmm]

I got rid of my remaining shares today was hoping to hold for long term capital gains tax but the report scared me along with the fear the market will start discounting the royalty as it approaches its end.

Surprised the stock held up this well!

[MikeDDKing]

Unilens Vision Reports Third Quarter Operating Results
Nine-Month Diluted E.P.S. of $0.30 Compare With $0.28 in Prior-Year Period
On Friday May 28, 2010, 12:01 pm

LARGO, FL--(Marketwire - 05/28/10) - Unilens Vision Inc. (OTC.BB:UVIC - News) (TSX-V:UVI - News), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the third quarter and first nine months of FY2010.

Royalty income for the quarter ended March 31, 2010 increased slightly to a third quarter record of $734,803, compared with $734,249 in the three months ended March 31, 2009. Sales of licensed products by the Company's licensee, Bausch & Lomb, continued to increase, resulting in higher royalty income.

Net sales excluding royalty income declined to $1,535,454 in the most recent quarter, versus $1,701,043 in the third quarter of FY2009. The decrease in sales was primarily due to a soft U.S. economy and increased competition from new product offerings and rebate programs.

FY2010 third quarter pretax income decreased 39.5% to $450,559, compared with $745,249 in the third quarter of FY2009. The decrease was primarily attributable to (1) a reduction in gross profit resulting from lower sales, (2) one-time administrative expenses of approximately $110,000 associated with stock compensation expense and the migration of the Company's corporate presence from Canada to the U.S., and (3) interest expense and amortization of loan fees of approximately $60,000 related to financing of the stock repurchase completed in January 2010.

After recording net income tax expense of $174,990, the Company reported net income of $275,569 in the most recent quarter, a decrease of 38.3% when compared with net income of $446,850 in the year-earlier quarter (after income tax expense of $298,399). The Company earned $0.10 per diluted share in the third quarter of FY2010, versus earnings of $0.10 per diluted share in the third quarter of FY2009. Diluted per-share earnings were calculated on 2,855,684 common shares in the FY2010 third quarter, versus 4,555,678 diluted shares in the prior-year quarter. The 37% decrease in average diluted shares resulted from the Company's repurchase of 2,188,861 outstanding shares of common stock on January 20, 2010.

"The decline in third quarter earnings was primarily due to the introduction of new products and marketing programs by certain competitors in the midst of an economic recession, combined with one-time administrative expenses," stated Michael Pecora, Chief Executive Officer of Unilens Vision Inc. "We have developed strategies to address recent competitive challenges and will continue to build upon our reputation as 'The Independent Eye Care Professionals' Contact Lens Company'. Meanwhile, our royalty income stream continues to grow as Bausch & Lomb utilizes our proprietary technology in new products and markets its contact lenses in an expanding number of countries around the world."

Royalty income for the nine months ended March 31, 2010 increased 6.6% to a record $2,253,865, compared with $2,114,215 in the first nine months of FY2009, demonstrating continued sales growth of licensed products by Bausch & Lomb.

For the nine months ended March 31, 2010, net sales excluding royalty income declined to $4,633,666, compared with $4,992,811 in the corresponding period of the previous fiscal year. Net sales of the Company's C-Vue brand disposable contact lenses increased approximately 0.5% during the first nine months of FY2010, while sales of custom lenses and replacement products continued to decline, as expected.

Pretax income for the nine months ended March 31, 2010 decreased 10.6% to $1,895,360, compared with $2,120,225 in the prior-year period. After recording net income tax expense of $700,395, the Company reported net income of $1,194,965, for the nine months ended March 31, 2010, versus net income (after income tax expense of $848,063) of $1,272,162 in the first nine months of FY2009. The Company earned $0.30 per diluted share in the nine months ended March 31, 2010, versus earnings per diluted share of $0.28 in the prior-year period. Diluted per-share earnings were calculated on 3,998,122 common shares in the first nine months of FY2010, compared with 4,556,425 diluted shares in the corresponding period in FY2009. The 12% decrease in average diluted shares resulted from the Company's repurchase of 2,188,861 outstanding shares of common stock in January 2010.

About Unilens Vision Inc. -- "The Independent Eye Care Professionals' Contact Lens Company"

Established in 1989, Unilens Vision Inc., through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue® brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVIC" and on the Canadian TSX Venture Exchange under the symbol "UVI".

(Note: All financial information in this release is stated in U.S. Dollars.)

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

                           UNILENS VISION INC. 
                        THIRD QUARTER - FISCAL 2010 
               CONDENSED CONSOLIDATED FINANCIAL INFORMATION 
  
 (All figures in U.S. Dollars) 
  
 RESULTS OF OPERATIONS 
                               Three      Three 
                              Months     Months     Nine months  Nine months 
                               Ended      Ended        Ended        Ended 
                             March 31,   March 31,   March 31,    March 31, 
                               2010        2009        2010         2009 
                            ----------  ----------  -----------  ---------- 
   Sales                    $1,535,454  $1,701,043  $ 4,633,666  $4,992,811 
   Cost of sales               912,581     943,931    2,717,169   2,752,561 
                            ----------  ----------  -----------  ---------- 
                               622,873     757,112    1,916,497   2,240,250 
                            ----------  ----------  -----------  ---------- 
   Expenses                    827,865     731,093    2,204,063   2,206,395 
                            ----------  ----------  -----------  ---------- 
   (Loss) income from 
    operations                (204,992)     26,019     (287,566)     33,855 
   Other items: 
   Royalty income              734,803     734,249    2,253,865   2,114,215 
   Other expense               (16,059)    (12,917)     (15,236)    (19,406) 
   Remeasurement expense        (3,398)     (2,479)      (1,575)    (11,463) 
   Interest (expense) income   (59,795)        377      (54,128)      3,024 
                            ----------  ----------  -----------  ---------- 
                               655,551     719,230    2,182,926   2,086,370 
                            ----------  ----------  -----------  ---------- 
   Income before income tax 
    expense                    450,559     745,249    1,895,360   2,120,225 
   Income tax expense          174,990     298,399      700,395     848,063 
                            ----------  ----------  -----------  ---------- 
   Net income for the 
    period                  $  275,569  $  446,850  $ 1,194,965  $1,272,162 
                            ==========  ==========  ===========  ========== 
   Net income per common 
    share: 
     Basic                  $     0.10  $     0.10  $      0.30  $     0.28 
     Diluted                $     0.10  $     0.10  $      0.30  $     0.28 
                            ==========  ==========  ===========  ========== 
 CASH FLOWS 
                            ----------  ----------  -----------  ---------- 
 Provided (used) by: 
   Operating activities     $  398,389  $  960,719  $ 2,122,312  $2,255,774 
   Investing activities        237,343    (264,083)     477,219    (329,144) 
   Financing activities     (1,559,953)   (409,565)  (2,691,349) (2,593,908) 
                            ----------  ----------  -----------  ---------- 
   Increase (decrease) in 
    cash                    $ (924,221) $  287,071  $   (91,818) $ (667,278) 
                            ==========  ==========  ===========  ========== 
  
                            ==========  ==========  ===========  ========== 
  
 BALANCE SHEET 
                                        ----------  -----------  ---------- 
                                         June 30,     March 31,   March 31, 
                                           2009         2010        2009 
                                        ----------  -----------  ---------- 
   Cash and certificates of 
    deposit                             $1,678,626  $ 1,085,233  $1,174,735 
   Total assets                          5,749,661    4,552,449   5,529,389 
   Current liabilities                   1,056,312    2,444,815   1,024,441 
   Total liabilities                     1,056,312    7,044,815   1,024,441 
   Stockholders' equity 
    (deficit)                           $4,693,349  $(2,492,366) $4,504,948 
                                        ==========  ===========  ========== 

Contact:



For more information, please contact:
Leonard F. Barker
CFO
Unilens Vision Inc.
[phone]

[MikeDDKing]

Unilens Vision Inc. Declares Quarterly Cash Dividend of $0.09 Per Share
On Tuesday May 4, 2010, 9:02 am

LARGO, Fla., May 4 /PRNewswire-FirstCall/ -- The Unilens Vision Inc. (OTC Bulletin Board:UVIC.ob - News) (TSX Venture Exchange:UVI.v - News) Board of Directors yesterday declared a quarterly cash dividend of $0.09 per common share, payable May 28, 2010 to stockholders of record at the close of business on May 14, 2010.

"We are pleased to continue the $0.09 per share quarterly dividend. This is our 15th consecutive quarterly dividend, which on a annualized dividend rate of $0.36 per share provides a dividend yield of 6.5% based on the closing price of our common stock on Friday April 30, 2010," stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc.

About Unilens Vision Inc. – "The Eye Care Professionals Specialty Contact Lens Company"

Established in 1989, Unilens Vision Inc., a Delaware corporation, through its wholly owned subsidiary Unilens Corp., USA, located in Largo, Florida, develops, licenses, manufactures, distributes and markets contact lenses primarily under the C-Vue® brand directly to Independent Eye Care Professionals. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is listed on the OTC Bulletin Board under the symbol "UVIC" as well as the Canadian TSX Venture Exchange under the symbol "UVI".

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risk and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC and the TSX Venture Exchange. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

For more information, please contact:

Len Barker CFO, Unilens Vision Inc. at [phone]

[MikeDDKing]

UVIC insider purchases get a mention on thestreet.com.

http://www.thestreet.com/_yahoo/story/10735962/1/two-chipotle-insiders-sell-81m-worth.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA

[MikeDDKing]

Another form 4 was filed today for more UVIC insider purchases! 103,852 shares were purchased in the last few days by Baker Street Capital Management!

http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=7200898-2238-16665&type=sect&TabIndex=2&companyid=122791&ppu=%252fdefault.aspx%253fcik%253d852564

[MikeDDKing]

A 10% owner of UVIC just added 24,804 shares to his position!

http://www.sec.gov/Archives/edgar/data/852564/000119380510001115/xslF345/e606831_ex.xml

[MikeDDKing]

The symbol has changed to UVIC. I'll request a change for the board.